Why Is BPH Treatment Drug and Surgery Demand Rising Notably?

According to the United Nations Department of Economic and Social Affairs (UNDESA), the number of people aged 65 years or more will grow from 727 million in 2020 to around 1.5 billion by 2050.  The U.S. Census Bureau forecasts that the global population of men aged 55–59 years will reach 222,508,188; men within the age group 60–64 years will rise to 198,506,354; and men in the age bracket 65–69 years will surge to 160,741,527 by 2030. 

As elderly men are highly vulnerable to benign prostatic hyperplasia (BPH), the surging population of geriatric men will help the benign prostatic hyperplasia treatment market flourish during 2021–2030. According to P&S Intelligence, the market revenue will surge from about $10 billion in 2020 to around $17 billion by 2030. BPH or prostate gland enlargement occurs due to bladder or prostate cancer, kidney or bladder stones, urinary tract infections (UTI), scarring in the bladder neck caused due to previous surgeries, urethral stricture, and prostatitis. 

At present, medical professionals are prescribing drug treatments, such as alpha blockers and 5-alpha reductase inhibitors; and surgical treatments, such as laser therapy, prostatic stenting, rezûm therapy, transurethral needle ablation of the prostate (TUNA), transurethral resection of the prostate (TURP), and transurethral microwave thermotherapy (TUMT), for people suffering from BPH and associated disorders. Some of the widely accepted alpha blockers include tamsulosin, silodosin, doxazosin, and alfuzosin. Furthermore, doctors are also offering dutasteride and finasteride to BPH patients for non-invasive treatments. 

In the preceding years, the North American region led the benign prostatic hyperplasia treatment market, primarily on account of the rising geriatric population, which is extremely vulnerable to lower urinary tract diseases. The U.S. Census Bureau states that the population of individuals aged 65 years and above in the U.S. surged from 40.3 million in 2010 to 54.1 million in 2019. Additionally, the surging public awareness regarding BPH and the improving reimbursement coverage policy will also fuel the adoption of BPH treatment devices in the region.

Thus, the soaring number of elderly men will create a huge requirement for BPH treatment therapies and drugs in the upcoming years.

Get More Details Benign Prostatic Hyperplasia Treatment Market Regional Insights


Comments

Post a Comment

Popular posts from this blog

Huge Growth Expected in Dermacosmetics Market in Future

Image
 The cosmetic industry, while mostly misunderstood as dealing with just the aesthetic appearance, has been undergoing technological advancements and moved beyond face creams and face powders since a long time now. Other than this, the prevalence of skin diseases is also rising across the globe and it has been shown by the Global Burden of Disease project that skin diseases are the 4th leading cause of nonfatal disease burden globally. Moreover, understanding the impact of skin diseases is important as in some cases skin conditions often represent a more severe systemic illness, such as human immunodeficiency virus and neglected tropical diseases.  Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/dermacosmetics-market/report-sample Attributed to these reasons, the development of dermacosmetics has been made possible. These products are crucial now in the branch of dermatology as they combine cosmetics and scientific techniques for the management of a
Read more

Increasing Occurrence of Spinal Cord Injuries Powering Sales of Exoskeletons

Image
The growing prevalence of stroke and spinal cord injuries (SCIs) is fueling the surge in the demand for exoskeletons in several healthcare settings such as rehabilitation centers across the world. In the healthcare industry, exoskeletons are used for helping paralyzed patients walk. For example, as per the National Spinal Cord Injury Statistical Center (NSCISC), in the U.S., there are around 54 cases of SCIs per one million people, or nearly 17,730 new SCI cases are reported every year. Furthermore, in the U.S., the average number of people suffering from spinal cord injuries is 291,000, with various individual estimates falling in the range of 249,000–363,000. The surging geriatric population in several countries is also fueling the demand for exoskeletons. As per the World Population Ageing 2019 report published by the UN, the total number of people in the age bracket- 65 years or above across the world was 703 million in 2019. Moreover, the public awareness about exoskeletons and th
Read more

Why is Population Health Management Market Expected to Boom in North America in Future?

Image
 The soaring global geriatric population, which is expected to reach at least 1.5 billion by 2050, according to the World Health Organization (WHO), is a key factor responsible for the rise in the demand for population health management (PHM). Elderly people require extensive care as they are more susceptible to diseases, especially chronic diseases, such as cancer and cardiovascular ailments, owing to their low immunity levels and high recovery periods. This causes a huge increase in the demand for better prevention, diagnosis, and treatment processes. In addition to this, older people also have a greater requirement for personalized medicine, because of their increased susceptibility to drug allergy, thereby boosting the demand for population health management. Receive Sample Copy of this Report:  https://www.psmarketresearch.com/market-analysis/population-health-management-market/report-sample The other important factors bolstering the demand for PHM are the increasing healthcar
Read more